Chemoinformaics analysis of Ferulic Acid Hexoside
| Molecular Weight | 356.327 | nRot | 5 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 14 |
| Exact Molecular Weight | 356.111 | nRing | 2 |
| Solubility: LogS | -1.233 | nHRing | 1 |
| Solubility: LogP | -0.396 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 47.2739 |
| nHD | 5 | BPOL | 26.1401 |
| QED | 0.323 |
| Synth | 3.612 |
| Natural Product Likeliness | 1.971 |
| NR-PPAR-gamma | 0.272 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.727 |
| HIA | 0.917 |
| CACO-2 | -6.017 |
| MDCK | 0.000185196 |
| BBB | 0.743 |
| PPB | 0.680969 |
| VDSS | 0.414 |
| FU | 0.348452 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.061 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.308 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.736 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.3 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.038 |
| CL | 3.816 |
| T12 | 0.821 |
| hERG | 0.031 |
| Ames | 0.331 |
| ROA | 0.243 |
| SkinSen | 0.12 |
| Carcinogencity | 0.213 |
| EI | 0.01 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.138 |
| Antiviral | Yes |
| Prediction | 0.688671 |